Table 3 Comparison of Clinical and laboratory characteristics between neonates with RSV and viruses other than RSV
Clinical Parameters | RSV- LRIs | Other viruses LRIs | P Value |
|---|---|---|---|
n = 344 | n = 131 | ||
Demographic data | |||
Age (median, IQR) | 17 (12–22) | 17 (13–23) | 0.002 |
Sex (male, %) | 205 (59.6) | 70 (53.4) | 0.224 |
Birth weight (mean ± std, g) | 3380.5 ± 460.6 | 3390.8 ± 471.1 | 0.820 |
Underlying condition (n, %)a | 35 (10.2) | 11 (8.4) | 0.558 |
Clinical symptoms | |||
Cough (n, %) | 343 (99.7) | 131 (98.5) | 1.0 |
Fever (n, %) | 75 (21.8) | 46 (35.1) | 0.003 |
Wheezing (n, %) | 34 (9.9) | 12 (9.2) | 0.812 |
Tachypnea (n, %) | 174 (50.6) | 31 (23.7) | <0.001 |
Dyspnea (n, %) | 68 (19.8) | 17 (13.0) | 0.084 |
Cyanosis (n, %) | 18 (5.2) | 8 (6.2) | 0.708 |
Refusal to feed (n, %) | 14 (4.1) | 6 (4.6) | 0.804 |
Physical examination | |||
Moist rales (n, %) | 267 (77.6) | 72 (55.0) | <0.001 |
Wheezing rales (n, %) | 34 (9.9) | 12 (9.2) | 0.812 |
Laboratory tests | |||
White blood cells | 9.1 ± 2.7 | 9.2 ± 3.0 | 0.777 |
C-reactive protein (median, IQR) | 0.9 (0.3–2.6) | 0.6 (0.1–2.1) | 0.061 |
Alanine transarninase increase (n, %) | 20 (5.8) | 7 (5.3) | 0.843 |
Creatine kinase-MB increase (n, %) | 257 (74.7) | 85 (64.9) | 0.033 |
Abnormal chest X-ray (n, %) | 307 (89.2) | 67 (51.4) | <0.001 |
Theraphy | |||
Supplemental oxygen (n, %) | 59 (17.2) | 11 (8.4) | 0.016 |
Mechanical ventilation (n, %) | 15 (4.3) | 3 (2.3) | 0.291 |
Duration of hospital days (median, IQR) | 10 (9–12) | 8 (7–10) | <0.001 |